Brett D Allison

This inventor holds 18 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Janssen Pharmaceutica Nv, Araxes Pharma LLC. Active years: 2007-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brett D Allison. Retrieved from https://idiyas.com/inventor/brett-d-allison

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 3)

% Patents Active = 88.9

CIPO Patents = 4

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 6.1

ph-index = 3

Forward Citations = 77(Granted Patents)

Location History:

Del Mar, CA (US) (2007 - 2017)
San Diego, CA (US) (2018 - 2024)

Company Filing History:

17 out of 2,101

Janssen Pharmaceutica Nv

Years Active: 2007-2024

Loading Chart...

Areas of Expertise:

Pyrazole Derivatives

MALT1 Inhibitors

P2X7 Modulators

Quinazoline Compounds

Tetrahydro-Pyrimidoazepines

TRPV1 Modulators

Bicyclic Pyrazole Compounds

Antibacterial Agents

Sulfonamide Compounds

Benzo[1,2,5]Thiadiazole

Substituted Benzyl Amine

Quinoxaline Compounds

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12077521 - Pyrazole derivatives as MALT1 inhibitors (2024-09-03),

2. 10954214 - Pyrazole derivatives as MALT1 inhibitors (2021-03-23),

3. 10112937 - P2X7 modulators and methods of use (2018-10-30),

4. 9988357 - Methods for preparation of quinazoline derivatives (2018-06-05),

5. 9738649 - Tetrahydro-pyrimidoazepines as modulators of TRPV1 (2017-08-22),

6. 9422293 - Tetrahydro-pyrimidoazepines as modulators of TRPV1 (2016-08-23),

7. 8242275 - Bicyclic pyrazole compounds as antibacterial agents (2012-08-14),

8. 8232391 - Bicyclic pyrazole compounds as antibacterial agents (2012-07-31),

9. 7910582 - [object Object] (2011-03-22),

10. 7855292 - Sulfonamide compounds (2010-12-21),

11. 7842810 - Bicyclic pyrazole compounds as antibacterial agents (2010-11-30),

12. 7687499 - [object Object] (2010-03-30),

13. 7563895 - Quinoxaline compounds (2009-07-21),

14. 7550492 - Benzo[1,2,5]thiadiazole compounds (2009-06-23),

15. 7479493 - Substituted benzyl amine compounds (2009-01-20),

Title: The Innovative Contributions of Brett D Allison

Introduction

Brett D Allison is a prominent inventor based in Del Mar, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of 18 patents to his name, his work has had a considerable impact on medical research and treatment options.

Latest Patents

Among his latest patents are the pyrazole derivatives as MALT1 inhibitors. These patents disclose compounds, compositions, and methods for treating diseases, syndromes, conditions, and disorders that are influenced by the modulation of MALT1. The compounds are represented by a specific formula, which includes various defined components.

Career Highlights

Brett has worked with notable companies in the pharmaceutical industry, including Janssen Pharmaceutica and Araxes Pharma. His experience in these organizations has allowed him to develop innovative solutions that address complex medical challenges.

Collaborations

Throughout his career, Brett has collaborated with esteemed colleagues such as Michael D Hack and Victor K Phuong. These partnerships have further enhanced his research and development efforts.

Conclusion

Brett D Allison's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his dedication to advancing medical science. His work continues to influence the development of new treatments for various health conditions.

Profile summary based on public USPTO records.